SELLAS Life Sciences Group, Inc. (SLS) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 411.12M |
| Enterprise Value | 340.23M |
| P/E Ratio | -37.36 |
| PEG Ratio | -0.64 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 13.7 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -49.55 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.26 |
| Return On Equity | -0.47 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -26.86M |
| Net Income | -26.86M |
| Diluted EPS | -0.25 |
| Total Cash | 107.2M |
| Total Cash/Share | 0.62 |
| Total Debt | 871,000 |
| Total Debt/Equity | 0.01 |
| Current Ratio | 17.22 |
| Book Value Per Share | 0.62 |
| 52-Week Change | 398.83 |
| 52-Week High | 9.51 |
| 52-Week Low | 1.39 |
| Moving Average 50 Days | 6.52 |
| Moving Average 200 Days | 3.9 |
| Average Volume | 7.53M |
| Shares Outstanding | 142.44M |
| % Held by Institutions | 49.48 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:50 |
| Last Split Date | November 08, 2019 |